Terlipressin-induced skin necrosis.
作者信息
Jain Gaurav, Chandran Pooja, Patnaik Itish, Patel Nupur B
机构信息
Department of Anaesthesiology and Critical Care, AIIMS Rishikesh, Rishikesh, Uttarakhand, India.
Department of Gastroenterology, AIIMS Rishikesh, Rishikesh, Uttarakhand, India.
出版信息
BMJ Case Rep. 2021 Nov 29;14(11):e246678. doi: 10.1136/bcr-2021-246678.
Abstract
摘要
相似文献
1
Terlipressin-induced skin necrosis.特利加压素引起的皮肤坏死。
BMJ Case Rep. 2021 Nov 29;14(11):e246678. doi: 10.1136/bcr-2021-246678.
2
Ischemic Skin Necrosis in Hepatorenal Syndrome Patient Secondary to Terlipressin.特利加压素继发肝肾综合征患者的缺血性皮肤坏死
J Coll Physicians Surg Pak. 2019 Jun;29(6):S26-S28. doi: 10.29271/jcpsp.2019.06.S26.
3
Ischemic skin necrosis following terlipressin therapy: report of two cases and review of the literature.特利加压素治疗后缺血性皮肤坏死：两例报告并文献复习
Turk J Gastroenterol. 2012;23(6):788-91.
4
Clinical characteristics and treatment of terlipressin-induced ischemic skin necrosis: A synthesis of 35 literature reported cases.特利加压素引起的缺血性皮肤坏死的临床特征和治疗：35 篇文献报道病例的综合分析。
J Clin Pharm Ther. 2022 Aug;47(8):1270-1275. doi: 10.1111/jcpt.13671. Epub 2022 Apr 23.
5
Terlipressin-Induced Peripheral Cyanosis in a Patient with Liver Cirrhosis and Hepatorenal Syndrome.特利加压素致肝硬化合并肝肾综合征患者外周性发绀
Am J Case Rep. 2019 Jan 2;20:5-9. doi: 10.12659/AJCR.913150.
6
Ischemic skin necrosis secondary to the use of terlipressin.继发于特利加压素使用的缺血性皮肤坏死。
Rev Esp Enferm Dig. 2021 Aug;113(8):617. doi: 10.17235/reed.2020.7467/2020.
7
Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.特利加压素治疗肝肾综合征导致严重缺血性肠坏死。
Clin Mol Hepatol. 2013 Dec;19(4):417-20. doi: 10.3350/cmh.2013.19.4.417. Epub 2013 Dec 28.
8
Terlipressin-induced ischemic skin necrosis: a rare association.特利加压素诱发的缺血性皮肤坏死：一种罕见的关联。
Am J Case Rep. 2014 Oct 31;15:476-9. doi: 10.12659/AJCR.891084.
9
[Practice guidance for the use of terlipressin for liver cirrhosis-related complications (2021)].《特利加压素用于肝硬化相关并发症的实践指南（2021年）》
Zhonghua Gan Zang Bing Za Zhi. 2022 Aug 20;30(8):859-865. doi: 10.3760/cma.j.cn501113-20220525-00279.
10
Duodenal Necrosis and Nonvariceal Digestive Bleeding After Terlipressin Administration for Treatment of Hepatorenal Syndrome: a Case Report of a Novel Side Effect of a Commonly Used Drug.特利加压素治疗肝肾综合征后发生十二指肠坏死和非静脉曲张性消化道出血：一种常用药物的新的副作用的病例报告。
Transplant Proc. 2022 Jun;54(5):1391-1393. doi: 10.1016/j.transproceed.2022.03.023. Epub 2022 Jun 5.
引用本文的文献
1
Terlipressin-induced skin necrosis in cirrhotic patients-A case report and comprehensive literature review.特利加压素诱发肝硬化患者皮肤坏死——一例报告及文献综述
Clin Case Rep. 2024 Sep 29;12(10):e9141. doi: 10.1002/ccr3.9141. eCollection 2024 Oct.
2
Management of hepatic hydropericardium with open drainage, maximal medical therapy and terlipressin.经皮穿刺引流、最大药物治疗联合特利加压素治疗肝性心包积液。
BMJ Case Rep. 2024 Jan 12;17(1):e256908. doi: 10.1136/bcr-2023-256908.
3
An Uncommon Presentation of Vasopressin-Induced Purpura Fulminans.血管加压素诱导的暴发性紫癜的罕见表现。
J Med Cases. 2023 Apr;14(4):130-136. doi: 10.14740/jmc4062. Epub 2023 Apr 30.
本文引用的文献
1
Terlipressin-induced ischaemic skin necrosis.特利加压素诱导的缺血性皮肤坏死。
BMJ Case Rep. 2020 Jan 15;13(1):e233089. doi: 10.1136/bcr-2019-233089.
2
Terlipressin-induced ischemic skin necrosis: a rare association.特利加压素诱发的缺血性皮肤坏死：一种罕见的关联。
Am J Case Rep. 2014 Oct 31;15:476-9. doi: 10.12659/AJCR.891084.
Zotero 插件